Ventilator Market: Global Market and Forecast (2023-2029) by Mobility, Type, Interface, Mode, End User, and Region

Ventilator Market size was valued at USD 1.1 Bn. in 2022 and the total Ventilators revenue is expected to grow at 8.2% from 2023 to 2029, reaching nearly USD 1.92 Bn.
Ventilator Market Overview:
A ventilator, often known as a breathing machine or respirator, is a mechanism that helps people breathe. In hospitals, it is mostly used to treat chronic obstructive pulmonary disease (COPD), sleep apnea, acute lung damage, and hypoxemia. The Ventilator Market has grown tremendously over the years as a result of technical advances such as the creation of improved portable ventilators and breakthroughs in sensor technologies utilized in ventilators.

Preterm births, a fast geriatric population increase, a rising frequency of respiratory disorders, an increasing number of ICU beds, and a rising number of COVID-19 patients are expected to drive growth in the Ventilator Market during the forecast period. The rise of home healthcare has created new opportunities for the ventilator sector. Other important drivers driving development in the home healthcare market for ventilators are convenience and comfort in the home care setting, as well as cost advantages.

Additionally, the growing aging population, which is predisposed to developing chronic diseases, as well as the rising prevalence of chronic diseases such as chronic obstructive pulmonary disease (COPD), are driving the market. For example, according to the Australia Bureau of Statistics, in March 2022, 17.6% of females and 10.7% of males aged 75 years or older in Australia had asthma in 2020-2021.

Besides that, according to a research study published in September 2021 by the European Respiratory Society (ERS) titled "An estimate of the European prevalence of COPD in 2050," an estimated 36,580,965 Europeans were living with chronic obstructive pulmonary disease in 2020, and this number is expected to reach 49,453,852 by 2050. As a result, the rising prevalence of respiratory illnesses in the population is expected to increase the demand for ventilators, driving market growth.

However, the high cost of ventilator materials and processes, as well as the rising expense of healthcare systems, as well as rising occurrences of ventilator-associated pneumonia, are expected to restrict the market growth.To know about the Research Methodology :- Request Free Sample Report
Ventilator Market Dynamics:
Increasing COPD and asthma patients globally

COPD and asthma are among the most common respiratory diseases globally. According to the WHO, COPD is the third biggest cause of mortality globally, accounting for 3.23 million deaths in 2019. More than 80% of these fatalities happened in low- and middle-income nations. COPD affects an estimated 380 million people globally. Undiagnosed COPD patients are prevalent in China, India, Brazil, and Eastern Europe. COPD costs healthcare systems all across the globe USD 50 billion every year.

Long-term asthma and extended exposure to cigarette smoke, indoor and outdoor air pollution, and occupational gases and dust are all key causes of COPD. COPD is associated with other chronic illnesses such as cardiovascular disease, musculoskeletal disability, and diabetes mellitus. These illnesses may also influence patients' health and interfere with COPD care.

According to the WHO, around 262 million people suffered from asthma in 2019, with 0.5 million deaths. Morbidity and mortality remain significant concerns in asthma, and no medication has resulted in disease normalization. Globally, 100 million additional asthmatic sufferers are expected to be registered by end of the forecast period. Asthma affects one out of every twelve persons in the United States, and approximately ten million people over the age of 45 live in Europe. Every day, up to 1,000 individuals are expected to die as a result of asthma.

COPD and asthma both cause constriction of respiratory pathways, making breathing harder. As a result, a considerable percentage of individuals with COPD and asthma require external ventilation and airway care. As a result, the growing number of COPD and asthma patients is expected to increase demand for ventilators and drive market growth.

Growing prevalence of respiratory diseases across the globe to drive Ventilators Market

According to the World Health Organization, respiratory disorders account for more than 10% of all disability-adjusted life-years (DALYs), a statistic that reflects the amount of active and productive life lost as a result of a condition. Only cardiovascular illnesses outperform respiratory disorders in this regard (including stroke). COPD is third among the top 30 causes of mortality, followed by lower respiratory tract infection, tracheal, bronchial, and lung cancer, TB, and asthma. Acute or chronic respiratory ailments affect over a billion individuals globally. As a result, the increasing number of people with respiratory diseases is a major driver for ventilators market growth.

Growing prevalence of tobacco smoking among individuals

Smokers have a higher risk to suffer from lung disease, including lung cancer. They do, however, raise their chance of developing other ailments such as heart disease, stroke, and mouth (oral) cancer. According to the Centers for Disease Control and Prevention (CDC), smoking-related illnesses kill more than 480,000 individuals in the United States each year. Tobacco use is directly responsible for about 90% of lung cancer and COPD fatalities. Despite anti-smoking initiatives and health warnings, many individuals smoke or begin to smoke each year. Approximately 8% of children under the age of 18 are active smokers.

The most common cause of COPD is smoking. Tobacco kills up to 50% of its users, according to the WHO. More than 80% of the world's 1.3 billion smokers live in low- and middle-income nations. According to the CDC, cigarette smoking is still the biggest cause of avoidable illness, disability, and death in the United States, responsible for over 480,000 fatalities each year. In the United States, over 34.1 million individuals smoke cigarettes, and over 16 million Americans suffer from a smoking-related ailment.

Technological advancements in microprocessor-controlled ventilation

Technology advancements in microprocessor-controlled ventilation, along with the complexity of modern ventilator modes, have given multidisciplinary teams in healthcare organizations several chances to improve the care of critically sick patients on ventilators. Advanced ventilators are also prepared for any form of emergency and have several safeguards in place. Sensors and monitors are installed in patient-specific characteristics such as air pressure, air volume, and flow rate, as well as generic parameters such as air leakage, mechanical failure, power failure, battery backups, oxygen tanks, and remote control.

Portable life support ventilators are becoming lighter and smaller, including invasive, noninvasive, and mouthpiece ventilation options. To provide pleasant breathing and correct treatment, the sophisticated ventilation technology combines responsive leak and circuit compensation with precision flow trigger controls. Manufacturers have recently developed wirelessly linked portable ventilators in order to have a real influence on patient outcomes.

Current Bluetooth-enabled devices convert medical-grade data into usable information by connecting to a cloud-based patient management program, providing it straight to care professionals' mobile devices or PCs numerous times each day. This system enables care teams to remotely and proactively monitor patients, enabling quick and informed clinical choices, including early intervention, which can help reduce avoidable readmissions and save healthcare costs.

Significant population of undiagnosed & undertreated asthma and COPD patients

Asthma and COPD are two major respiratory disorders that go mostly undiagnosed and untreated. This is especially important in underdeveloped economies due to a lack of knowledge and proper resources to detect these disorders. According to the WHO, low- and middle-income countries account for more than 90% of COPD fatalities and 80% of asthma deaths. COPD develops slowly and is typically detected in adults over the age of 40, making it difficult to treat in the later stages of life.

It is believed that around 70% of COPD patients go undetected owing to a lack of knowledge. As with COPD, around 50% of asthmatics are undiagnosed and undertreated. A large number of untreated individuals with respiratory disorders restrict the utilization of ventilators and this is a key challenge for ventilators market growth during the forecast period.
Ventilator Market Segment Analysis:
By Interface, the Non-invasive ventilation segment dominated the market with the highest market share in 2022 and is expected to grow at a CAGR of 7.7% and maintain its dominance at the end of the forecast period. The use of non-invasive ventilators in a wide range of applications, as well as their capacity to provide accurate and higher oxygen concentrations, are significant drivers driving the segment's expansion. Non-invasive ventilation can be provided utilizing modern intensive-care ventilators with many respiratory support modes.

Extensive R&D investments in the healthcare industry, as well as rising per capita income, drive total market growth. The key reason driving the growth of the Continuous positive airway pressure (CPAP) devices market is an increase in the number of patients suffering from respiratory disorders. The CPAP accounted for more than 35.0% of total sales in the non-invasive ventilation mode category. These devices are utilized as an oxygen supply for people suffering from respiratory difficulties in emergency rooms and hospitals. CPAP equipment can also help patients receiving cardiac therapy get enough oxygen.

Non-invasive mechanical ventilation is increasingly being utilized to prevent or replace intubation across various hospitals. It increases survival and decreases complications in selected individuals with acute respiratory failure when compared to medicinal treatment and, in some cases, invasive mechanical ventilation. Exacerbation of chronic obstructive pulmonary disease, cardiogenic pulmonary oedema, pulmonary infiltrates in immunocompromised patients, and weaning of previously intubated stable individuals with chronic obstructive pulmonary disease are the major indications.Additionally, this approach can be utilized in postoperative patients or those with neurological illnesses, to relieve symptoms in terminally sick patients, or to aid in bronchoscopy; however, more research is needed in these cases before it can be considered first-line treatment. In an intensive care or high-dependency unit, non-invasive ventilation should be used as an alternative to intubation. It can be safely provided in an appropriately staffed and supervised ward to prevent intubation in otherwise stable patients.

Non-invasive ventilation has mostly been utilized in emergency departments to treat acute respiratory failure in individuals with cardiogenic pulmonary oedema. Several meta-analyses found that this method, including CPAP, is superior to standard medical care for lowering intubation rates. They also discovered that CPAP lowers mortality. Non-invasive breathing improved physiological outcomes quicker than oxygen alone but had no statistically significant effect on intubation or death.

Non-invasive ventilation usage varies widely between hospitals and geographical locations, and it has evolved through time. A worldwide perspective assessment of mechanical ventilation found that utilization increased rapidly. It is becoming more popular in many nations, but the frequency of use varies greatly. Non-invasive ventilation is mostly used to treat chronic obstructive pulmonary disease (COPD) exacerbations and cardiogenic pulmonary oedema. Use for hypoxic respiratory failure and weaning facilitation is relatively uncommon and is mostly done in specialized centers.
Ventilator Market Regional Insights:
North American market held the largest market share of about 56% and dominated the market in 2021 and is expected to grow at a CAGR of 7.9% during the forecast period. The existence of top manufacturers implementing production increases, as well as the growing number of critically sick COVID-19 patients in the United States (4,813,647 as of 3 August 2020), are significant drivers driving the regional market.In addition, the rising prevalence of obstructive pulmonary disease (COPD) and respiratory disorders, the presence of well-established healthcare infrastructure, and the presence of major market players in the region drive regional growth. To assist the government with the lack of this equipment, American automakers such as Tesla, Ford, and GM have shifted their production lines for medical supplies such as masks, mechanical ventilators, and other medical devices. As a result, the regional market witnessed significant growth.

Non-invasive ventilation is most commonly initiated in emergency departments in North America, with most patients being moved to critical care units or step-down units in hospitals that provide such capabilities. The low rate of utilization in certain hospitals is due to a lack of expertise or experience with the treatment, a lack of technical equipment, and insufficient financing. Despite these restrictions, this approach is being utilized in settings other than conventional and respiratory critical care units, such as emergency departments, postsurgical recovery rooms, cardiology, neurology, cancer wards, and palliative care units.

According to the Society of Critical Care Medicine, the supply of hospital ventilators in the United States was around 160,000 units in the first quarter of 2020. However, according to the American Association for Respiratory Care, there were over 8.6 million active COVID-19 cases as of July 2022, and an estimated 960,000 Americans need mechanical assistance to breathe during the pandemic. Thus, mechanical ventilators saw an unexpected rise in demand in the United States during the COVID-19 pandemic (2020), which is expected to drive market growth throughout the forecast period.

Similarly, according to research issued by the Centers for Disease Control and Prevention (CDC), in March 2020, more than 53% of COVID-19-related hospitalizations were admitted to the critical care unit. According to a study published in Critical Care in February 2021 by Silvio A. amends-Silva et al., in Mexico, about 15.3% of hospitalized patients required invasive mechanical ventilation (IMV), while 70.8% of patients got IMV outside the ICU. Thus, rising patient admissions to the critical care unit as a result of COVID-19 are expected to increase demand for ventilators and drive market growth.

In addition, Chronic obstructive pulmonary disease (COPD) is the third largest cause of mortality in the United States, according to the American Lung Association 2021. The chronic obstructive pulmonary disease has been identified in about 16.4 million persons (COPD). Chronic obstructive pulmonary disease (COPD) causes substantial long-term impairment and premature mortality, necessitating a greater need for ventilators, producing money for the industry.

Thus, rising critical care admissions and the development of new ventilation modes, such as acute non-invasive ventilation, which avoids lung damage, are expected to drive the growth of the mechanical ventilator market, increasing the region's market growth.

In addition, the Asia Pacific market is expected to grow significantly during the forecast period due to the growing cases of COVID-19 variants, chronic lung diseases, rising healthcare expenditure, multiple collaborations, new product launches, and strategic agreements implemented by local players during the pandemic. For example, in January 2021, CSIR-NAL developed Swasth Vayu, a non-invasive airway pressure ventilator.Similarly, Spicejet launched Spiceoxy, a portable, non-invasive ventilation system, in August 2020. The advent of such low-cost items is expected to increase their acceptance during the forecast period. Additionally, growth in this region is related to the development of infrastructure and healthcare regulations that promote better care for citizens. The increasing prevalence of respiratory illnesses due to lifestyle factors such as smoking and hereditary allergy developments drives the market growth.
Ventilator Market Scope: Inquire before buying



Ventilator Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2018 to 2022
Market Size in 2022:
US $ 1.1 Bn.


Forecast Period 2023 to 2029 CAGR:
8.2%
Market Size in 2029:
US $ 1.92 Bn.


 Segments Covered:
by Mobility
1. Intensive care ventilators
2. Portable/ transportable ventilators


by Type
1. Adult/pediatric ventilators
2. Neonatal/infant ventilators


by Interface
1. Invasive ventilation segment
2. Non-invasive ventilation


by Mode
1. Combined-mode ventilation
2. Volume-mode ventilation
3. Pressure-mode ventilation
4. Other ventilation modes


by End User
1. Hospitals & clinics
2. Home care settings
3. Ambulatory care centers
4. Emergency medical services



Ventilator Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)
Ventilator Market, Key Players are
1. ResMed (US)
2. Medtronic(US)
3. Bio-Med Devices, Inc.(US)
4. Hill-Rom Holdings, Inc.(US)
5. Vyaire Medical, Inc.(US)
6. Allied Healthcare Products, Inc.(US)
7. Avasarala Technologies Ltd(US)
8. GE Healthcare(US)
9. Fisher & Paykel Healthcare Limited(US)
10. Drägerwerk AG & CO. KGAA (Germany)
11. aXcent Medical GmbH (Germany)
12. HEYER Medical AG(Germany)
13. Metran Co., Ltd.(Japan)
14. Nihon Kohden Corporation (Japan)
15. Asahi Kasei Corporation(Japan)
16. Air Liquide (France)
17. Hamilton Medical (Switzerland)
18. Smiths Group plc.(UK)
19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.(China)
20. MAGNAMED (Brazil)
21. Airon Corporation(US)
22. TRITON Electronic Systems Ltd.(Russia)
23. Leistung Engineering Pvt. Ltd.(India)
24. Koninklijke Philips N.V.(Netherlands)
25. Getinge AB (Sweden)

FAQs:

1. Which is the dominating market for the Ventilators in terms of the region at the end of the forecast period?
Ans. North America is the potential market for the Ventilators in terms of the region at the end of the forecast period.

2. What are the opportunities for new market entrants?
Ans. The key opportunity in the market is Technological advancements in microprocessor-controlled ventilation.

3. What is expected to drive the growth of the Ventilator Market in the forecast period?
Ans. A major driver in the Ventilator market is the Increasing number of COPD and asthma patients globally.

4. What is the projected market size & growth rate of the Ventilator Market?
Ans. Ventilator Market size was valued at USD 1.1 Bn. in 2022 and the total Ventilators revenue is expected to grow at 8.2% from 2023 to 2029, reaching nearly USD 1.92 Bn.

5. What segments are covered in the Ventilator Market report?
Ans. The segments covered are Mobility, Type, Interface, Mode, End User, and Region.